Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Recurrence 2Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Liver Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Erectile Dysfunction 1Carcinoma, Hepatocellular 1

Interventions

Tadalafil 1Surveys and Questionnaires 1Saline Solution 1Holistic Health 1Educational Status 1Cell- and Tissue-Based Therapy 1Androgen Antagonists 1Ambulatory Care Facilities 14-Aminopyridine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Erectile Dysfunction × Cell- and Tissue-Based Therapy × 1 year × Clear all
NCT01089387 2025-12-04

INSTIN

Institut National de la Santé Et de la Recherche Médicale, France

Phase 1/2 Completed
18 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡